What happens if I choose no treatment for Testicular Cancer

Understanding "Watch and Wait" for Testicular Cancer

This is an important question, and I appreciate you asking it directly. Let me explain what the medical evidence shows about observation without immediate treatment for testicular cancer.

How Doctors Think About This Decision

According to the medical literature and patient experiences documented in testicular cancer resources, oncologists approach the "no treatment" question by considering several factors:

• Stage of your cancer (early-stage vs. advanced)
• Type of testicular cancer (seminoma vs. non-seminoma, which behave differently)
• Tumor markers (blood tests that indicate cancer activity)
• Your overall health and preferences
• Risk of progression based on your specific pathology

What "No Treatment" Generally Means

"No treatment" doesn't mean doing nothing—it typically means active surveillance (also called "watch and wait"):

✅ What happens during surveillance:

• Regular blood tests to monitor tumor markers (AFP, beta-hCG, LDH)
• Periodic imaging (CT scans, chest X-rays) on a schedule your doctor determines
• Physical exams at set intervals
• Close monitoring for any signs of progression

❌ What you're NOT doing:

• Surgery to remove the affected testicle (orchiectomy)
• Chemotherapy
• Radiation therapy

The Clinical Reality

For early-stage testicular cancer (Stage 1):

• Some patients with favorable-risk disease can safely use surveillance
• If cancer progresses, treatment can be started when detected
• This approach preserves treatment options for later if needed

If you choose no surveillance at all (truly doing nothing):

• Cancer can progress silently without detection
• By the time symptoms appear (pain, swelling, fatigue), the disease may be more advanced
• Treatment options may be more limited
• Cure rates are significantly lower

Important Context from Patient Experiences

Scott Petinga, a testicular cancer survivor who shared his journey, emphasized that early-stage testicular cancer treatments were historically based on outdated approaches. He advocated for patients to:

• Take time to understand their specific situation
• Get second opinions
• Understand the differences between treatment options
• Ask doctors about their experience with different approaches

His key message: Don't rush into decisions, but DO stay informed and engaged with your care.

Questions to Ask Your Oncologist

Based on NCCN Guidelines for shared decision-making, ask your doctor:

1. What is my specific stage and risk category? (This determines if surveillance is even an option)
2. If surveillance is appropriate for me, what does the schedule look like? (How often will I have blood work and imaging?)
3. What signs of progression should I watch for? (What symptoms mean I need to contact you?)
4. What happens if my tumor markers rise or imaging shows changes? (What's the plan if surveillance detects progression?)
5. What are the cure rates with surveillance vs. immediate treatment for MY specific situation?
6. How experienced are you with surveillance protocols for testicular cancer?
7. Can I get a second opinion on whether surveillance is appropriate for me?

The Bottom Line

For testicular cancer specifically, completely avoiding all treatment AND monitoring is generally not recommended because:

• Early detection of progression leads to better outcomes
• Testicular cancer is highly curable when caught early
• Surveillance allows you to avoid treatment if cancer doesn't progress, while staying alert

However, active surveillance (monitoring without immediate treatment) IS a legitimate option for many patients with early-stage disease—and it's very different from doing absolutely nothing.

Your specific situation depends on your cancer stage, type, and risk factors. This is exactly the kind of decision that requires a detailed conversation with your oncology team about YOUR particular case.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.